Orion settles patent dispute with Wockhardt
This article was originally published in Scrip
Executive Summary
Orion and Wockhardt's two subsidiaries in the US have reached a settlement agreement over their patent dispute regarding Orion's two Parkinson's disease treatments. Subject to the court's approval, all the patents, including US patents Nos 5,446,194; 5,135,950; 6,599,530; 6,797,732; and 6,500,867, should remain in place.